Drawing for ALLTAQ

USPTO serial 79227907

ALLTAQ

Reviewed by CopyMark Law Group

Reg. 5790162Status 709
Filing date
Status date
Registration date
Jul 2, 2019
Examiner
KING, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLTAQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Randolph E. Digges, III

Randolph E. Digges, III Rankin, Hill & Clark LLPP.O. BOX 1150BONITA SPRINGS, FL 34133-1150UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely, buffer solutions used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloningSECTION 71 - CANCELLED—
005Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 16, 2026C71TCANCELLED SECTION 71—
Jul 2, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 5, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 13, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 24, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 20, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 8, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 19, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 19, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 2, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 2, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 17, 2019LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 23, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 14, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 22, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 11, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 27, 2018CHPNPOST PUBLICATION AMENDMENT – NOT ENTERED—
Nov 24, 2018GPNXNOTIFICATION PROCESSED BY IB—
Nov 20, 2018APETASSIGNED TO PETITION STAFF—
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2018EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 24, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 24, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 6, 2018RFNTREFUSAL PROCESSED BY IB—
Mar 19, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 19, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 13, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 5, 2018DOCKASSIGNED TO EXAMINER—
Mar 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance